HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
BCMA and Other Targets April 10, 2021 Myeloma Round Table
BCMA and Other Targets April 10, 2021 Myeloma Round Table image
HealthTree Round Tables for Multiple Myeloma Chapter
event Apr 10, 2021 / 12:00PM - 01:15PM EDT

Event Description

B-cell maturation agent (BCMA), which is expressed on the surface of virtually all myeloma cells, has been called “the perfect target” for novel therapies including antibody drug conjugates (ADCs), CAR T, bispecific T-cell engagers (BiTEs or bispecifics), and new immunotherapies like trispecifics.  This program will be a deep dive into why these targets are important, how their mechanisms function, and how they are being integrated into myeloma therapy.

Watch the April 10, 2021 Round Table

BCMA and Other Targets


Questions Answered in Chat Forum


Schedule & Agenda

BCMA and Other Targets in Myeloma Therapy
Welcome and Introduction
BCMA and Other Targets in Myeloma Therapy
Understanding the mechanisms of BCMA and other targets 
BCMA and Other Targets in Myeloma Therapy
Therapies targeting BCMA
BCMA and Other Targets in Myeloma Therapy
Audience questions and answers

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Greg Brozeit
Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.

Read Bio
The panelist Alexander Lesokhin, MD
Alexander Lesokhin, MD

Alexander Leshokin, MD, is a Hematologic Oncologist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, NY who specializes in myeloma and immunology. His research work involves developing innovative ways to use the immune system to treat cancer. He conducts clinical studies of medicines that enhance the immune response as well as laboratory studies aimed at understanding how cancers such as multiple myeloma are able to evade the immune response with a goal of developing new ways to treat myeloma patients. Dr. Leshokin completed his fellowship at MSKCC and his residency at New York-Presbyterian Hospital/Columbia University Medical Center. He earned his medical degree at the Albert Einstein College of Medicine in New York.

Read Bio
The panelist Krina Patel, MD, MSc
Krina Patel, MD, MSc

Krina Patel, MD, MSc, is Associate Professor and Center Medical Director in the Department of Lymphoma/Myeloma of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center (MDACC) in Houston, TX. She treats only patients with plasma cell dyscrasias and is Principal Investigator for multiple ongoing phase I/II and III immune-oncology and maintenance clinical trials for myeloma patients. Her research interests include myeloma, developing cellular therapies like CAR T, and combining immunotherapy and chemotherapy in the induction, transplant, maintenance and salvage settings and she has completed significant clinical research in hematopoeitic stem cell transplantation. Dr. Patel completed her Hematology Oncology fellowship at MDACC and served as Chief Fellow. She received her MSc for a translational project she completed in the laboratory of Dr. Laurence Cooper, evaluating the combination of CAR T cells and TCR engineered cells with vaccine in in vitro and in vivo myeloma models. She served her clinical residency in internal medicine at the University of Texas UT Health in Houston, TX and earned her medical degree at the University of Texas Southwestern Medical Center in Dallas, TX.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


+1 800 709 1113


Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube